36
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association of childhood blood-lead levels with cognitive function and socioeconomic status at age 38 years and with IQ change and socioeconomic mobility between childhood and adulthood

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Importance

          Many children in the US and around the world are exposed to lead, a developmental neurotoxin. The long-term cognitive and socioeconomic consequences of lead exposure are uncertain.

          Objective

          To test the hypothesis that childhood lead exposure is associated with cognitive function and socioeconomic status in adulthood and with changes in IQ and socioeconomic mobility between childhood and midlife.

          Design, Setting, and Participants

          Prospective cohort study based on a population-representative 1972–73 birth cohort from New Zealand, the Dunedin Multidisciplinary Health and Development Study, followed to age 38 years (December, 2012).

          Exposure

          Childhood lead exposure ascertained as blood-lead levels measured at 11 years. High blood-lead levels were observed among children from all socioeconomic status levels in this cohort.

          Main Outcomes and Measures

          The IQ (primary outcome) and indexes of Verbal Comprehension, Perceptual Reasoning, Working Memory, and Processing Speed (secondary outcomes) were assessed at 38 years using the Wechsler Adult Intelligence Scale–IV (WAIS-IV; IQ range 40–160). Socioeconomic status (primary outcome) was assessed at 38 years using the New Zealand Socioeconomic Index-2006, (NZSEI-06; range 10=lowest-90=highest).

          Results

          Of 1037 original participants, 1007 were alive at 38 years, of whom 565 (56%) had been lead tested at 11 years (54% male; 93% white). Mean blood-lead level at 11 years was 10.99μg/dL (SD=4.63). Among blood-tested participants included at 38 years, mean WAIS-IV score was 101.16 (SD=14.82) and mean NZSEI-06 score was 49.75 (SD=17.12). After adjusting for maternal IQ, childhood IQ, and childhood socioeconomic status, each 5μg/dL higher level of blood-lead in childhood was associated with a 1.61-point lower score (95%CI:−2.48, −0.74) in adult IQ, a 2.07-point lower score (95%CI: −3.14, −1.01) in Perceptual Reasoning, and a 1.26-point lower score (95%CI: −2.38, −0.14) in Working Memory. Lead-associated deficits in Verbal Comprehension and Processing Speed were not statistically significant. After adjusting for confounders, each 5μg/dL higher level of blood-lead in childhood was associated with a 1.79-unit lower score (95%CI: −3.17, −0.40) in socioeconomic status. An association between greater blood-lead levels and a decline in IQ and socioeconomic status from childhood to adulthood was observed, with 40% of the association with downward mobility mediated by cognitive decline from childhood.

          Conclusion and Relevance

          In this cohort born in New Zealand in 1972–1973, childhood lead exposure was associated with lower cognitive function and socioeconomic status at age 38 years and with declines in IQ and downward social mobility. Childhood lead exposure may have long-term ramifications.

          Related collections

          Author and article information

          Journal
          7501160
          5346
          JAMA
          JAMA
          JAMA
          0098-7484
          1538-3598
          13 April 2017
          28 March 2017
          29 June 2017
          : 317
          : 12
          : 1244-1251
          Affiliations
          [1 ]Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
          [2 ]Center for Genomic and Computational Biology, Duke University, Durham, NC, USA
          [3 ]Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
          [4 ]Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, & Neuroscience, King’s College, London, UK
          [5 ]Social Science Research Institute, Duke University, Durham, NC, USA
          [6 ]Department of Medicine, Duke University School of Medicine, Durham, NC, USA
          [7 ]Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, New Zealand
          [8 ]Dunedin Multidisciplinary Health and Development Research Unit, Department of Psychology, University of Otago, Dunedin, New Zealand
          Author notes
          Corresponding author: Aaron Reuben, Department of Psychology and Neuroscience, Duke University, Durham, NC, 27708. Tel: 919-684-6684. aaron.reuben@ 123456duke.edu
          Article
          PMC5490376 PMC5490376 5490376 nihpa865176
          10.1001/jama.2017.1712
          5490376
          28350927
          b5c8f5ad-82e7-40db-8439-2ed912f5ad3e
          History
          Categories
          Article

          Comments

          Comment on this article